Mariner’s Biomea Fusion BMEA Stock Holding History

Mariner’s Portfolio BMEA Stock Details BMEA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$874K	Sell	594,726 -59,852	-9%	-$89.3K	﹤0.01%	2051
2026 Q1	$1M	Buy	654,578 +68,946	+12%	+$90.6K	﹤0.01%	1970
2025 Q4	$726K	Buy	585,632 +346,702	+145%	+$486K	﹤0.01%	2186
2025 Q3	$483K	Buy	+238,930	New	+$438K	﹤0.01%	2461

Other funds holding BMEA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

ACM

Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

FISPB

Fideuram - Intesa Sanpaolo Private Banking Turin $3.33B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Mariner's BMEA Position: Q2 2026 in Review

Mariner reduced its Biomea Fusion (BMEA) stake by 9.1% in Q2 2026, selling an estimated $89.3K and leaving 594,726 shares worth $874K. The position accounts for ﹤0.01% of the portfolio, ranked #2051.

Mariner first reported a position in BMEA in Q3 2025 and has held it in 4 quarters since. The position peaked at $1M in Q1 2026. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

Mariner held 594,726 shares of Biomea Fusion worth $874K as of Q2 2026.
Mariner sold 59,852 Biomea Fusion shares in Q2 2026, an estimated $89.3K.
Biomea Fusion made up ﹤0.01% of Mariner's portfolio in Q2 2026, its #2051 holding.
Mariner first reported a position in Biomea Fusion in Q3 2025 and has held it in 4 quarters since.
Mariner's Biomea Fusion position peaked at $1M in Q1 2026.
61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.